Sartorius Stedim Biotech. 

Sartorius Stedim Biotech S.A. serves as a leading global supplier, providing essential equipment and expendable materials to the biopharmaceutical industry. The company's comprehensive product lineup supports a broad spectrum of bioprocesses, including cell culture growth media, diverse cell lines, and advanced bioreactor systems. It also offers specialized solutions for isolating, purifying, and concentrating biological substances, alongside systems designed for the secure storage and transport of both intermediate and finished biological products. Moreover, Sartorius Stedim Biotech develops innovative single-use and reusable hollow-fiber membrane devices, as well as pre-sterilized assemblies specifically tailored for cutting-edge cell and gene therapy applications. Their portfolio extends to tools for cell harvesting and various other sophisticated solutions aimed at enhancing the efficiency of bioprocesses. Complementing its hardware, the company provides analytical software engineered to model and optimize critical stages of biopharmaceutical development and production. Beyond its product offerings, Sartorius Stedim Biotech delivers comprehensive services in areas such as cell cultivation, fermentation, filtration, purification, and fluid management. Its diverse clientele encompasses manufacturers across the pharmaceutical, food, and chemical sectors, in addition to numerous research and development institutions. Established in 1870 and headquartered in Aubagne, France, the organization operates as a subsidiary of Sartorius AG.